Skip navigation
Agenda

Tracking Emerging State Price Transparency, Reporting & Disclosure Laws to Ensure Compliance

September 27, 2018
  • Philadelphia, PA

Agenda

Want more agenda details? Download the brochure.

SEPTEMBER 27, 2018

7:30

Registration and Continental Breakfast

8:15

Chairperson’s Welcome and Opening Remarks

Sabrina Yohai
Vice President, Policy, Access & Value, Corporate Legal
Vertex Pharmaceuticals Inc.

8:30

State Drug Pricing Reporting Requirements and Interpretations — What You Need to Know Now to Ensure Reporting Compliance

William A. Sarraille
Partner
Sidley Austin LLP

9:30

Federal Legislative Activity — American Patients First Update

Seth Lundy
Partner
King & Spalding LLP

10:15

Implications of State Drug Pricing Transparency Laws on Policy

MODERATOR:

Vince Sampson
Partner
Cooley LLP

PANELISTS:

Joanne Chan
Assistant General Counsel
Pharmaceutical Research and Manufacturers of America (PhRMA)

Angela Marcucci
Director of Global Policy
Pfizer Inc

Kendra Martello
Senior Director, Public Policy, Government Affairs & Public Policy
Mallinckrodt Pharmaceuticals

11:15

Networking and Refreshment Break

11:45

California SB-17 — Implementation and Enforcement Update

Sarah diFrancesca
Partner
Cooley LLP

12:15

Oregon HB 4005 — Reporting Requirements Overview and Update

William A. Sarraille
Partner
Sidley Austin LLP

12:45

Networking Luncheon

1:30

Operational Best Practices Focused on Governance and Planning for the Future

Andrew Parks
Director
KPMG

2:15

PANEL DISCUSSION:The Impact of Transparency and Disclosure Legislation on
Legal and Compliance Practices

MODERATOR:

Brian A. Bohnenkamp
Partner, FDA & Life Sciences Practice
King & Spalding LLP

PANELISTS:

Debbie A. Walters
Vice President, Assistant General Counsel
Pfizer Inc

Sabrina Yohai
Vice President, Policy, Access & Value, Corporate Legal
Vertex Pharmaceuticals Inc.

3:15

Networking and Refreshment Break

3:45

The Latest Developments for New York’s Medicaid Drug Cap and the Impact of ICER on Drug Pricing

William A. Sarraille
Partner
Sidley Austin LLP

4:15

State Transparency Documentation Challenges and Reporting Best Practices

 

5:00

Close of Conference

Agenda

Want more agenda details? Download the brochure.

Want more agenda details? Download the brochure.

SEPTEMBER 27, 2018

7:30

Registration and Continental Breakfast

8:15

Chairperson’s Welcome and Opening Remarks

Sabrina Yohai
Vice President, Policy, Access & Value, Corporate Legal
Vertex Pharmaceuticals Inc.

8:30

State Drug Pricing Reporting Requirements and Interpretations — What You Need to Know Now to Ensure Reporting Compliance

William A. Sarraille
Partner
Sidley Austin LLP

9:30

Federal Legislative Activity — American Patients First Update

Seth Lundy
Partner
King & Spalding LLP

10:15

Implications of State Drug Pricing Transparency Laws on Policy

MODERATOR:

Vince Sampson
Partner
Cooley LLP

PANELISTS:

Joanne Chan
Assistant General Counsel
Pharmaceutical Research and Manufacturers of America (PhRMA)

Angela Marcucci
Director of Global Policy
Pfizer Inc

Kendra Martello
Senior Director, Public Policy, Government Affairs & Public Policy
Mallinckrodt Pharmaceuticals

11:15

Networking and Refreshment Break

11:45

California SB-17 — Implementation and Enforcement Update

Sarah diFrancesca
Partner
Cooley LLP

12:15

Oregon HB 4005 — Reporting Requirements Overview and Update

William A. Sarraille
Partner
Sidley Austin LLP

12:45

Networking Luncheon

1:30

Operational Best Practices Focused on Governance and Planning for the Future

Andrew Parks
Director
KPMG

2:15

PANEL DISCUSSION:The Impact of Transparency and Disclosure Legislation on
Legal and Compliance Practices

MODERATOR:

Brian A. Bohnenkamp
Partner, FDA & Life Sciences Practice
King & Spalding LLP

PANELISTS:

Debbie A. Walters
Vice President, Assistant General Counsel
Pfizer Inc

Sabrina Yohai
Vice President, Policy, Access & Value, Corporate Legal
Vertex Pharmaceuticals Inc.

3:15

Networking and Refreshment Break

3:45

The Latest Developments for New York’s Medicaid Drug Cap and the Impact of ICER on Drug Pricing

William A. Sarraille
Partner
Sidley Austin LLP

4:15

State Transparency Documentation Challenges and Reporting Best Practices

 

5:00

Close of Conference